Last Price$217.97NASDAQ Previous Close - Last Trade as of 1:00PM ET 11/26/21

Today's Change+17.90(8.95%)
Bid (Size)$218.98 (2)
Ask (Size)$219.80 (1)
Day Low / High$213.50 - 221.72
Volume6.2 M

View Biotechnology IndustryPeer Comparison as of 11/26/2021


Novavax Inc ( NASDAQ )

Price: $217.97
Change: +17.90 (8.95%)
Volume: 6.2 M
1:00PM ET 11/26/2021

Exact Sciences Corp ( NASDAQ )

Price: $85.46
Change: -2.63 (2.99%)
Volume: 1.3 M
1:00PM ET 11/26/2021

Repligen Corp ( NASDAQ )

Price: $286.01
Change: +14.17 (5.21%)
Volume: 438.4 K
1:00PM ET 11/26/2021

Incyte Corp ( NASDAQ )

Price: $68.38
Change: +1.64 (2.46%)
Volume: 3.2 M
1:00PM ET 11/26/2021

Biomarin Pharmaceutical Inc ( NASDAQ )

Price: $87.58
Change: -1.99 (2.22%)
Volume: 1.0 M
1:00PM ET 11/26/2021

Read more news Recent News

Insider Sell: Novavax
5:40PM ET 11/24/2021 MT Newswires

Gregory M Glenn, President, Research & Development, on November 23, 2021, sold 8,250 shares in Novavax (NVAX) for $1,645,914. Following the Form 4 filing...

Novavax Seeks Interim Authorization of COVID-19 Vaccine in Singapore
9:46AM ET 11/24/2021 MT Newswires

Novavax (NVAX) said Wednesday it is seeking interim authorization of its COVID-19 vaccine from the Singapore Health Sciences Authority through a special...

Insider Sell: Novavax
5:31PM ET 11/17/2021 MT Newswires

Gregory M Glenn, President, R&D, on November 15, 2021, sold 9,433 shares in Novavax (NVAX) for $1,601,676. Following the Form 4 filing with the SEC, Glenn...

Novavax Says European Medicines Agency Has Begun Review of its COVID-19 Vaccine Filing; Shares Rise
10:03AM ET 11/17/2021 MT Newswires

Novavax (NVAX) said Wednesday that European Medicines Agency has begun its evaluation of an application for conditional marketing authorization for the...

View all Commentary and Analysis

Novavax: Some Burning Questions
7:29AM ET 11/25/2021 Seeking Alpha

Novavax: So Near And Yet So Far
6:30AM ET 11/15/2021 Seeking Alpha

BioNTech: The Novavax Fork In The Road
3:22AM ET 11/15/2021 Seeking Alpha

Novavax Screams Buy
7:00AM ET 11/10/2021 Seeking Alpha

Company Profile

Business DescriptionNovavax, Inc. focuses on the discovery, development and commercialization of vaccines to prevent infectious diseases. It provides vaccines for COVID-19, seasonal flu, respiratory syncytial virus, Ebola, and Middle East respiratory syndrome. The company was founded in 1987 and is headquartered in Gaithersburg, MD. View company web site for more details
Address21 Firstfield Road
Gaithersburg, Maryland 20878
Number of Employees379
Recent SEC Filing11/24/20214
President, Chief Executive Officer & DirectorStanley C. Erck
Chief Operating Officer & Executive Vice PresidentRichard Crowley
Chief Financial Officer, Treasurer & Executive VPJames Patrick Kelly
President-Research & DevelopmentGregory M. Glenn

Company Highlights

Price Open$214.67
Previous Close$200.07
52 Week Range$106.11 - 331.68
Market Capitalization$16.5 B
Shares Outstanding75.6 M
SectorHealth Technology
Next Earnings Announcement03/07/2022

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$14.82
Beta vs. S&P 500N/A
Revenue$34.3 M
Net Profit Margin-89.31%
Return on Equity-149.66%

Analyst Ratings as of 08/30/2021

Consensus RecommendationConsensus Icon
Powered by Factset